 |
 |
 |
 |
 |
|||||||
 |
|
 |
 |
 |
 |
 |
 |
Innovation at LacProOur initial research is focused broadly on gastrointestinal ailments, with a specific emphasis on therapies for Clostridium difficile Infection (CDI). Our aim is to produce groundbreaking medical foods and biotherapeutics to improve patients’ lives and reduce the total cost of health care treatments in hospitals and long-term care facilities. Our proprietary probiotic strain, Lactobacillus delbrueckii spp. bulgaricus B-30892 (LDB B-30892), has demonstrated effectiveness in outpatient, hospital and long-term care facility settings for patients and residents with CDI, Inflammatory Bowel Disease. |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|||
 |
LacPro a Finalist for the 2009 Innovation of the Year Mira Award
LacPro Industries, LLC, a new probiotic-based biotherapeutic company, was selected as a finalist for the Innovation of the Year Award. LacPro, a Fort Wayne based company, is developing a new biologic for the prevention and treatment of Clostridium difficile Infection (CDI). |
 |
|
 |
|||
 |
 |
 |
 |
 |
Now in its 10th year, the 2009 TechPoint Mira Awards presented by BKD CPAs & Advisors are the premier technology awards program in the state of Indiana. Since the year 2000, TechPoint has honored Indiana businesses, schools and universities, and individuals for their contributions to the state’s technology-related economy. TechPoint’s prestigious Mira Awards program recognizes leaders and innovators in 11 different business categories, including two new categories—Healthcare IT Innovation and Excellence in Corporate IT.
 |
|||||||||
 |
 |
 |
|||||||
 |
LacPro Industries, LLC 2020 E. Washington Blvd. Suite 700 Fort Wayne, IN 46803 |
 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
 |
 |
 |
||